Base to Base biotech podcast 45: Chronic pain, urology, Affibody molecules and radioligand therapy
Johnson & Johnson prostate cancer drug receives CHMP positive opinion
Breakthru Medicine emerges from stealth to develop cancer drugs
FDA Rare Pediatric Disease designation for mucopolysaccharidosis Type II treatment
Faster and more reliable dementia diagnosis
Base to Base biotech podcast 36: Gothenburg, Charcot-Marie-Tooth disease and Ultrasound AI
SAS Clinical Acceleration debuts to modernise clinical trials and accelerate time to market
China’s first AI drug completes phase III trial
Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?
Ryght AI and Biorasi to partner on AI
Novel gene therapy for ALS cleared for trials in US and China
Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins